两种SLC4A11新型变异在患有先天性遗传性内皮缩症患者中的致病性和功能分析
Tianjiao Zhen1, Ya Li2, Qingge Guo2
1Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.
Translational vision science & technology
|October 3, 2023
概括
这项研究在一个先天性遗传性内皮缩症 (CHED) 家族中发现了两种新型SLC4A11变异. 这种K263R变体导致了线粒体功能障碍,但抗氧化剂SkQ1显示出保护作用,这表明了对CHED的潜在新疗法.
科学领域:
- 遗传学 遗传学 是一个
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
背景情况:
- 先天性遗传性内皮缩症 (CHED) 是一种遗传性眼睛疾病.
- SLC4A11基因在角膜内皮功能中起着至关重要的作用.
- 在SLC4A11的新变体可以导致CHED,但它们的确切机制尚未完全理解.
研究的目的:
- 在CHED.中调查两个新的SLC4A11变异的致病性和功能.
- 为了分析SLC4A11 (K263R) 突变的体外功能.
- 探索对CHED的潜在治疗干预措施.
主要方法:
- 对CHED患者进行眼科检查.
- 整体外体和桑格测序用于突变识别.
- 在体外研究中,使用感染了野生型和突变SLC4A11的HEK293T细胞,并用SkQ1.1治疗.
- 测量细胞呼吸,活性氧物种 (ROS),线粒体膜潜力和亡.
主要成果:
- 在CHED家族中发现了两种新型异构性SLC4A11变异.
- 证实c.1464-1G>T变种具有病原性.
- 在c.788A>G (p.Lys263Arg) 变异导致ROS和亡的增加,线粒体膜潜力的降低和体外氧气消耗.
- SkQ1治疗减轻了这些负面影响.
结论:
- 在CHED家族中发现了两种新型致病性SLC4A11变异.
- 该SLC4A11 (K263R) 变体诱导线粒体功能障碍和亡.
- 抗氧化剂SkQ1表现出一种保护作用,表明其作为CHED的新型治疗剂的潜力.
相关概念视频
Glucose Transporters
22.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Cystic Fibrosis: Pathogenesis
269
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
269
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16


